Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Toxicity testing in the 21st century: using the new toxicity testing paradigm to create a taxonomy of adverse effects.

Boekelheide K, Campion SN.

Toxicol Sci. 2010 Mar;114(1):20-4. doi: 10.1093/toxsci/kfp307. Epub 2009 Dec 21.

3.

Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.

Bushnell PJ, Kavlock RJ, Crofton KM, Weiss B, Rice DC.

Neurotoxicol Teratol. 2010 May-Jun;32(3):313-28. doi: 10.1016/j.ntt.2010.02.002. Epub 2010 Feb 17.

PMID:
20171276
4.

Toxicity testing in the 21st century: a vision and a strategy.

Krewski D, Acosta D Jr, Andersen M, Anderson H, Bailar JC 3rd, Boekelheide K, Brent R, Charnley G, Cheung VG, Green S Jr, Kelsey KT, Kerkvliet NI, Li AA, McCray L, Meyer O, Patterson RD, Pennie W, Scala RA, Solomon GM, Stephens M, Yager J, Zeise L.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):51-138. doi: 10.1080/10937404.2010.483176.

5.

Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening.

Nel A, Xia T, Meng H, Wang X, Lin S, Ji Z, Zhang H.

Acc Chem Res. 2013 Mar 19;46(3):607-21. doi: 10.1021/ar300022h. Epub 2012 Jun 7. Review.

6.
7.

New directions in toxicity testing.

Krewski D, Westphal M, Al-Zoughool M, Croteau MC, Andersen ME.

Annu Rev Public Health. 2011;32:161-78. doi: 10.1146/annurev-publhealth-031210-101153. Review.

PMID:
21219154
9.

Contribution of new technologies to characterization and prediction of adverse effects.

Rouquié D, Heneweer M, Botham J, Ketelslegers H, Markell L, Pfister T, Steiling W, Strauss V, Hennes C.

Crit Rev Toxicol. 2015 Feb;45(2):172-83. doi: 10.3109/10408444.2014.986054. Epub 2015 Jan 23. Review.

PMID:
25615431
10.
11.

A 21st century paradigm for evaluating the health hazards of nanoscale materials?

Walker NJ, Bucher JR.

Toxicol Sci. 2009 Aug;110(2):251-4. doi: 10.1093/toxsci/kfp106. Epub 2009 May 25.

12.

Toxicity testing in the 21 century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways.

Bhattacharya S, Zhang Q, Carmichael PL, Boekelheide K, Andersen ME.

PLoS One. 2011;6(6):e20887. doi: 10.1371/journal.pone.0020887. Epub 2011 Jun 20. Review.

13.

Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.

Phalen RF.

Hum Exp Toxicol. 2010 Jan;29(1):11-4. doi: 10.1177/0960327109354660.

PMID:
20061462
14.

The future of toxicity testing.

Andersen ME, Al-Zoughool M, Croteau M, Westphal M, Krewski D.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):163-96. doi: 10.1080/10937404.2010.483933. Review.

PMID:
20574896
15.

Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.

Zhang Q, Bhattacharya S, Andersen ME, Conolly RB.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):253-76. doi: 10.1080/10937404.2010.483943.

PMID:
20574901
16.

Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.

Schwartz SL.

Hum Exp Toxicol. 2010 Jan;29(1):15-9. doi: 10.1177/0960327109354657.

PMID:
20061463
17.

Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.

Llorens J, Li AA, Ceccatelli S, Suñol C.

Neurotoxicology. 2012 Aug;33(4):796-804. doi: 10.1016/j.neuro.2012.01.019. Epub 2012 Feb 7.

PMID:
22342764
18.

Toxicity testing in the 21st century: how will it affect risk assessment?

Rhomberg LR.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):361-75. doi: 10.1080/10937404.2010.483951.

PMID:
20574908
19.

The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans.

Blaauboer BJ, Boekelheide K, Clewell HJ, Daneshian M, Dingemans MM, Goldberg AM, Heneweer M, Jaworska J, Kramer NI, Leist M, Seibert H, Testai E, Vandebriel RJ, Yager JD, Zurlo J.

ALTEX. 2012;29(4):411-25.

20.

ECVAM and new technologies for toxicity testing.

Bouvier d'Yvoire M, Bremer S, Casati S, Ceridono M, Coecke S, Corvi R, Eskes C, Gribaldo L, Griesinger C, Knaut H, Linge JP, Roi A, Zuang V.

Adv Exp Med Biol. 2012;745:154-80. doi: 10.1007/978-1-4614-3055-1_10. Review.

PMID:
22437818
Items per page

Supplemental Content

Write to the Help Desk